A missense variant in complement factor B (CFB ) is a potential predictor of 24-week off-treatment response to PegIFNα therapy in Chinese HBeAg-positive chronic hepatitis B patients

Author:

Chen Haitao1ORCID,Sun Jian1ORCID,Zhou Bin1,Peng Jinxin1,Xie Qing2,Liang Xieer1,Fan Rong1,Conran Carly3,Xu Jianfeng4,Ji Yuan3,Zhang Xinxin2,Sun Li5,Jia Jidong6ORCID,Wang Guiqiang67,Hou Jinlin1ORCID,Jiang De-Ke1ORCID

Affiliation:

1. GuangZhou China

2. Shanghai China

3. Chicago IL USA

4. Evanston IL USA

5. Xiamen China

6. Beijing China

7. Hangzhou China

Funder

the Postdoctoral Science Foundation of China, China

the Innovative Research Team Project of Guangxi Province, China

the National Science and Technology Major Project, China

the Grant for Recruited Talents to Start Scientific Research from Nanfang Hospital, China and the Outstanding Youths Development Scheme of Nanfang Hospital, Southern Medical University, China

the Key-Areas Research and Development Program of Guangdong Province, China

the General Programs from the National Natural Science Foundation of China, China

the Local Innovative and Research Teams Project of Guangdong Pearl River Talents Program, China

the National Natural Science Foundation of China, China

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3